Nxera Pharma
4565.T
HK$39.78
Share price
9.46%
Change (1 day)
-52.43%
Change (1 year)
Categories
EPS for Nxera Pharma (4565.T)
EPS in 2024 (TTM): -HK$6.23
According to Nxera Pharma's latest financial reports the company's current EPS (TTM) is -HK$6.18. In 2023 the company made an earnings per share (EPS) of -HK$4.80 a decrease over its 2022 EPS that were of HK$0.28.
EPS history for Nxera Pharma from 2005 to 2024
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2024 (TTM) | -HK$6.23 | 29.82% |
| 2023 | -HK$4.80 | -1829.25% |
| 2022 | HK$0.28 | -67.15% |
| 2021 | HK$0.85 | -40.17% |
| 2020 | HK$1.41 | 5.97% |
| 2019 | HK$1.33 | -124.17% |
| 2018 | -HK$5.52 | -157.64% |
| 2017 | HK$9.57 | -691.98% |
| 2016 | -HK$1.62 | -366.52% |
| 2015 | HK$0.61 | -74.61% |
| 2014 | HK$2.39 | 45.12% |
| 2013 | HK$1.65 | -142.56% |
| 2012 | -HK$3.87 | 4.42% |
| 2011 | -HK$3.70 | 18.94% |
| 2010 | -HK$3.11 | -52.47% |
| 2009 | -HK$6.55 | -161% |
| 2008 | HK$10.74 | -205.26% |
| 2007 | -HK$10.20 | 23.33% |
| 2006 | -HK$8.27 | 42.13% |
| 2005 | -HK$5.82 |